Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ascelia Pharma AB | 2,115,198 | net | 15 Apr 2025 | tx 30+3,557,023−1,441,825 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Apr 2025 | OTHER | Ascelia Pharma AB | 92,304 | 2.15 SEK | deriv |
| 03 Sept 2024 | SALE | Ascelia Pharma AB | 131,965 | 0.14 SEK | deriv |
| 03 Sept 2024 | PURCHASE | Ascelia Pharma AB | 6,456 | 5.07 EUR | |
| 03 Sept 2024 | OTHER | Ascelia Pharma AB | 10,493 | 0.00 SEK | |
| 03 Sept 2024 | PURCHASE | Ascelia Pharma AB | 23,256 | 5.07 SEK | |
| 03 Sept 2024 | OTHER | Ascelia Pharma AB | 37,791 | 0.00 SEK | deriv |
| 26 Aug 2024 | SALE | Ascelia Pharma AB | 131,965 | 0.14 SEK | deriv |
| 26 Aug 2024 | SALE | Ascelia Pharma AB | 913,965 | 0.17 SEK | deriv |
| 05 Dec 2023 | OTHER | Ascelia Pharma AB | 818,071 | 0.00 SEK | |
| 05 Dec 2023 | OTHER | Ascelia Pharma AB | 1,770,490 | 0.00 SEK | |
| 05 Dec 2023 | OTHER | Ascelia Pharma AB | 131,965 | 0.00 SEK | |
| 15 Feb 2023 | PURCHASE | Ascelia Pharma AB | 3,000 | 14.98 SEK | first after silence |
| 16 Feb 2023 | PURCHASE | Ascelia Pharma AB | 3,000 | 15.12 SEK | |
| 16 Feb 2023 | PURCHASE | Ascelia Pharma AB | 6,000 | 15.12 SEK | |
| 16 Feb 2023 | PURCHASE | Ascelia Pharma AB | 1,195 | 15.18 SEK | |
| 17 Feb 2023 | PURCHASE | Ascelia Pharma AB | 3,000 | 15.52 SEK | |
| 17 Feb 2023 | PURCHASE | Ascelia Pharma AB | 296 | 16.26 SEK | |
| 17 Feb 2023 | PURCHASE | Ascelia Pharma AB | 3,000 | 16.56 SEK | |
| 17 Feb 2023 | PURCHASE | Ascelia Pharma AB | 3,000 | 16.98 SEK | |
| 21 Dec 2021 | OTHER | Ascelia Pharma AB | 132,974 | 0.00 SEK | |
| 21 Dec 2021 | OTHER | Ascelia Pharma AB | 250,000 | 0.00 SEK | |
| 26 May 2020 | PURCHASE | Ascelia Pharma AB | 10,000 | 20.38 SEK | |
| 25 May 2020 | PURCHASE | Ascelia Pharma AB | 493 | 19.94 SEK | |
| 26 May 2020 | PURCHASE | Ascelia Pharma AB | 8,290 | 21.50 SEK |
1 purchase reported after at least 12 months of silence — most recent on 15 Feb 2023.